Medicare go-broke date pushed back to 2031
Although the go-broke date for a pivotal trust fund that props up Medicare was extended by three years, stakeholders urge that action is needed in Washington to address Medicare’s long-term solvency.
Uncategorized
Biden administration announces appeal to ACA preventive mandate ruling
The Justice Department on Friday filed to appeal a Thursday ruling by a Texas judge striking down part of the ACA that requires health plans to fully cover certain preventive medical services like HIV and cancer screenings.
Biden administration announces appeal to ACA preventive mandate ruling Read More »
CMS increases MA rate bump for 2024
Driving the rate hike is the agency’s decision to phase in the technical risk adjustment changes over three years.
Grassroots innovation: How a patient-driven device for diabetes won FDA clearance
Tidepool Loop, an automated insulin dosing app based on one developed by the DIY diabetes community, received FDA clearance in January.
Grassroots innovation: How a patient-driven device for diabetes won FDA clearance Read More »
Predecir la flexibilidad de movimiento del ADN a nivel molecular
Tanto en física como en química, la escala mesoscópica se refiere a la escala de longitud en la que se puede estudiar las propiedades de un material o fenómeno, sin tener que discutir el comportamiento de los átomos individuales. En una modelización mesosc&o …
Predecir la flexibilidad de movimiento del ADN a nivel molecular Read More »
Vedere Bio II Closes Doors After Preclinical Studies Fall Short
Almost two years after its launch, eye-focused gene therapy start-up Vedere Bio II is closing its doors, company leaders announced through a LinkedIn post over the weekend.
Vedere Bio II Closes Doors After Preclinical Studies Fall Short Read More »
Crean nanopartículas para terapias genéticas en los pulmones
El ARN mensajero tiene un gran potencial terapéutico para tratar diversas enfermedades causadas por genes defectuosos. Hasta ahora, uno de los obstáculos para su aplicación ha sido lo difícil que resulta administrarlo en la parte correcta del cuerpo, sin efectos secundari …
Crean nanopartículas para terapias genéticas en los pulmones Read More »
Un restaurante ovetense, en la cima del cachopo asturiano
¿Dónde podemos comer el mejor cachopo asturiano en España? Que nuestro país es uno de los que mayor influencia tienen sobre la gastronomía mundial no es ningún secreto para nadie. Históricamente, España siempre ha sido considerada com …
Un restaurante ovetense, en la cima del cachopo asturiano Read More »
KILL Alzamend Neuro Receives FDA “Study May Proceed” Letter for Phase I/IIA Trial Under Its Investigational New Drug Application for an Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type
Alzamend Neuro, Inc. requests that their press release NewsItemId: 20230403005455 “Alzamend Neuro Receives FDA “Study May Proceed” Letter for Phase I/IIA Trial Under Its Investigational New Drug Application for an Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type” be killed.
AISA Pharma Announces NIH-NINDS Award to investigate Profervia® as a non-opioid analgesic for acute and chronic pain
Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, announces that the National Institute of Neurological Disorders and Stroke (NINDS)- National Institutes of Health (NIH) have awarded the Preclinical Screening Pain Platform (PSPP) award to Aisa’s Profervia® (cilnidipine), a once-daily novel, investigational, oral calcium-channel antagonist.